+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Drug Discovery Services Market by Process, Drug Type, Service type, Therapeutic Area, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5146254
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Drug Discovery Services Market grew from USD 21.77 billion in 2023 to USD 24.79 billion in 2024. It is expected to continue growing at a CAGR of 14.37%, reaching USD 55.75 billion by 2030.

Drug discovery services encompass a range of activities aimed at identifying new pharmaceutical candidates, screening compounds, and testing their efficacy and safety in the early stages of drug development. This field is crucial due to the increasing demand for novel therapeutics driven by rising global healthcare needs, advancing diseases, and expiring patents for existing drugs. Applications of these services spread across pharmaceutical, biotechnological, and academic research institutions, aiming to streamline R&D processes, reduce costs, and enhance success rates in drug development. The end-user scope includes large pharmaceutical companies, small to medium enterprises in biotechnology, academic institutions, and contract research organizations (CROs).

Key growth factors influencing this market include technological advancements like artificial intelligence and machine learning, which enhance drug discovery processes by improving data analytics and predictive modeling. Additionally, personalized medicine and the growing focus on rare diseases present lucrative opportunities. The rapid progression of biotechnology, coupled with increasing collaboration between academic institutions and industry players, further propels market development. However, challenges such as the high costs associated with drug discovery, stringent regulatory requirements, and the lengthy approval process can hinder market growth. Additionally, scientific and technical risks involved in identifying viable drug candidates remain substantial obstacles.

To capitalize on emerging opportunities, market players are recommended to invest in data-driven technologies and enhance their high-throughput screening capabilities. Collaborating with academic and research institutions can foster innovation and grant access to cutting-edge discoveries. Emphasizing the development of personalized and precision medicines by leveraging genomics and proteomics could yield substantial market advantages. Potential areas of innovation include improving drug-repurposing techniques and utilizing advanced computational models for drug design. The market is competitive yet promising, with significant opportunities for growth through strategic partnerships, technological integration, and addressing unmet medical needs. Key to success will be balancing cost-efficiency with rapid deployment of novel drug discovery methodologies.

Understanding Market Dynamics in the Drug Discovery Services Market

The Drug Discovery Services Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Growing R&D investments in the pharmaceutical & biopharmaceutical industry
    • Attractive rise in demand for outsourcing analytical testing and clinical trial services
    • Research on rare diseases and orphan drugs
  • Market Restraints
    • Expensive drug discovery and development
  • Market Opportunities
    • Development in the biologics and focus on drug discovery
    • Potential associated with expiry of patents
  • Market Challenges
    • Strict government rules for drug discovery and animal usage

Exploring Porter’s Five Forces for the Drug Discovery Services Market

Porter’s Five Forces framework further strengthens the insights of the Drug Discovery Services Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Drug Discovery Services Market

External macro-environmental factors deeply influence the performance of the Drug Discovery Services Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Drug Discovery Services Market

The Drug Discovery Services Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Drug Discovery Services Market

The Drug Discovery Services Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Drug Discovery Services Market

The Drug Discovery Services Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Discovery Services Market, highlighting leading vendors and their innovative profiles. These include Aganitha AI Inc., Agilent Technologies, Inc., Aurigene Discovery Technologies, BellBrook Labs, BioAscent Discovery Ltd., Charles River Laboratories International, Inc., Domainex Ltd., Enzo Life Sciences Inc., Eurofins Scientific SE, Frontage Laboratories, Inc., GenScript Biotech Corporation, Integrated DNA Technologies, Inc., IQVIA Inc, Jubilant Biosys Ltd., Labcorp Drug Development, Merck KGaA, Piramal Pharma Solutions, Proteros biostructures GmbH, Sai Life Sciences Limited, Schrödinger, Inc., Selvita S.A., Shanghai ChemPartner, Shanghai Medicilon, Inc., Symeres, Syngene International Limited, TCG Lifesciences Pvt. Limited, Thermo Fisher Scientific Inc., UCB S.A., Viva Biotech, and Wuxi Apptec.

Market Segmentation & Coverage

This research report categorizes the Drug Discovery Services Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Process
    • Candidate Validation
    • Hit-to-Lead Identification
    • Lead Optimization
    • Target Selection
    • Target Validation
  • Drug Type
    • Biologics
    • Small Molecules
  • Service type
    • Biology Services
    • Chemistry Services
  • Therapeutic Area
    • Cardiovascular Diseases
    • Digestive System Diseases
    • Neurology
    • Oncology
  • End-user
    • Academic Institutes
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing R&D investments in the pharmaceutical & biopharmaceutical industry
5.1.1.2. Attractive rise in demand for outsourcing analytical testing and clinical trial services
5.1.1.3. Research on rare diseases and orphan drugs
5.1.2. Restraints
5.1.2.1. Expensive drug discovery and development
5.1.3. Opportunities
5.1.3.1. Development in the biologics and focus on drug discovery
5.1.3.2. Potential associated with expiry of patents
5.1.4. Challenges
5.1.4.1. Strict government rules for drug discovery and animal usage
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Drug Discovery Services Market, by Process
6.1. Introduction
6.2. Candidate Validation
6.3. Hit-to-Lead Identification
6.4. Lead Optimization
6.5. Target Selection
6.6. Target Validation
7. Drug Discovery Services Market, by Drug Type
7.1. Introduction
7.2. Biologics
7.3. Small Molecules
8. Drug Discovery Services Market, by Service type
8.1. Introduction
8.2. Biology Services
8.3. Chemistry Services
9. Drug Discovery Services Market, by Therapeutic Area
9.1. Introduction
9.2. Cardiovascular Diseases
9.3. Digestive System Diseases
9.4. Neurology
9.5. Oncology
10. Drug Discovery Services Market, by End-user
10.1. Introduction
10.2. Academic Institutes
10.3. Pharmaceutical & Biotechnology Companies
11. Americas Drug Discovery Services Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Drug Discovery Services Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam
13. Europe, Middle East & Africa Drug Discovery Services Market
13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom
14. Competitive Landscape
14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. DRUG DISCOVERY SERVICES MARKET RESEARCH PROCESS
FIGURE 2. DRUG DISCOVERY SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DRUG DISCOVERY SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DRUG DISCOVERY SERVICES MARKET DYNAMICS
TABLE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 44. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 46. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 47. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 49. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 52. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 71. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 73. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 74. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 76. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 78. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 79. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 86. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 88. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 89. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 116. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 118. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 119. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 132. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 135. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 137. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 139. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 140. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 142. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 144. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 145. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 149. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 150. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 152. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 154. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 155. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 162. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 164. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 165. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 177. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 179. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 180. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 182. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 184. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 185. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 187. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 189. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 190. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 207. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 209. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 210. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 222. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 224. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 225. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Drug Discovery Services Market, which are profiled in this report, include:
  • Aganitha AI Inc.
  • Agilent Technologies, Inc.
  • Aurigene Discovery Technologies
  • BellBrook Labs
  • BioAscent Discovery Ltd.
  • Charles River Laboratories International, Inc.
  • Domainex Ltd.
  • Enzo Life Sciences Inc.
  • Eurofins Scientific SE
  • Frontage Laboratories, Inc.
  • GenScript Biotech Corporation
  • Integrated DNA Technologies, Inc.
  • IQVIA Inc
  • Jubilant Biosys Ltd.
  • Labcorp Drug Development
  • Merck KGaA
  • Piramal Pharma Solutions
  • Proteros biostructures GmbH
  • Sai Life Sciences Limited
  • Schrödinger, Inc.
  • Selvita S.A.
  • Shanghai ChemPartner
  • Shanghai Medicilon, Inc.
  • Symeres
  • Syngene International Limited
  • TCG Lifesciences Pvt. Limited
  • Thermo Fisher Scientific Inc.
  • UCB S.A.
  • Viva Biotech
  • Wuxi Apptec

Methodology

Loading
LOADING...

Table Information